Genus Capital Management Inc.
Source: SEC Form 13F · as of Mar 2026Genus Capital Management Inc. holds 14 biotech & pharma companies tracked by BioSniper, totaling $79.9M in value as of Mar 2026 (SEC Form 13F).
Companies held
14
Total value held
$79.9M
| Company | Shares | Value |
|---|---|---|
| GILDGILEAD SCIENCES, INC. | 119,280 | $16.6M |
| AMGNAMGEN INC | 44,427 | $15.6M |
| JNJJOHNSON & JOHNSON | 55,935 | $13.7M |
| MRKMerck & Co., Inc. | 102,986 | $12.4M |
| UTHRUNITED THERAPEUTICS Corp | 8,885 | $5.3M |
| MCKMcKesson Corporation | 4,958 | $4.3M |
| LLYELI LILLY & Co | 3,450 | $3.2M |
| CORCencora Inc. | 8,820 | $2.8M |
| INCYIncyte Corp. | 20,795 | $2.0M |
| IDXXIDEXX LABORATORIES INC /DE | 2,522 | $1.4M |
| GMOptec International, Inc. | 13,000 | $969K |
| ABBVAbbVie Inc. | 3,498 | $761K |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 12,510 | $690K |
| NVSNovartis AG | 1,557 | $238K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.